Source: PHARMAC
A simple change in how ambulance medicines are funded is set to create more consistent emergency care.
Pharmac is proposing changes to the Pharmaceutical Schedule to support the Government’s decision to shift responsibility for funding ambulance medicines from Health New Zealand and ACC to Pharmac.
With Pharmac already funding community and hospital medicines, this proposal would see Pharmac funding most medicines used by publicly funded health services.
Pharmac’s Director Strategy, Policy and Performance Michael Johnson said it made sense for Pharmac to take over responsibility for funding ambulance medicines.
“The vast majority of medicines used across the public health system are already funded by Pharmac; therefore, it makes sense for us to take over the funding of ambulance medicines as well.
“Not only will this ensure more consistent treatment between ambulance services and hospitals, it will also ensure the best prices for medicines used by ambulance services.
Johnson said the funding change wouldn’t mean any changes to the care provided by ambulance services but could mean long-term benefits for providers and the health system.
“These changes support seamless care for people transferred by ambulance to public hospitals, with both hospitals and ambulances able to access the same medicines, through the same agency, at the best price.”
“We also plan to work with ambulance service providers to establish regular communication and clear guidance to support individual funding requests for new medicines and better understand the ambulance-unique working environment.”
Public consultation on the proposal is open from 12 March and closes at 5pm 2 April 2026. You can email your feedback to consult@pharmac.govt.nz or use the online form.
